SanBio Company Limited (OTCMKTS:SNBIF) Sees Large Decrease in Short Interest

SanBio Company Limited (OTCMKTS:SNBIF) was the recipient of a significant decrease in short interest in June. As of June 15th, there was short interest totalling 1,213,500 shares, a decrease of 15.3% from the May 31st total of 1,433,100 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

SanBio Price Performance

Shares of SanBio stock remained flat at C$3.85 on Monday. SanBio has a 12-month low of C$3.80 and a 12-month high of C$4.25. The business has a 50-day moving average price of C$3.85 and a 200-day moving average price of C$3.87.

SanBio Company Profile

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson's disease, spinal cord injury, and Alzheimer's disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis.